On 30 May 2016
Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 30 May 2016, to approve The Audited Financial Results for the Financial Year 2015-16, Financial Statement of the Company for the Financial Year 2015-16 and matters related thereto, & consider recommendation of final dividend to the Members of the company for Financial Year 2015-16.Powered by Capital Market - Live News
